Clinical response in advanced non-small cell lung cancer with high PD-L1 expression and MET exon 14 skipping mutation: a case analysis of overcoming immunotherapy resistance and literature review - Poll - MDSpire

Clinical response in advanced non-small cell lung cancer with high PD-L1 expression and MET exon 14 skipping mutation: a case analysis of overcoming immunotherapy resistance and literature review

  • By

  • Yefei Ruan

  • Lin Qiu

  • May 12, 2026

  • 0 min

Share

Original Source(s)

Clinical response in advanced non-small cell lung cancer with high PD-L1 expression and MET exon 14 skipping mutation: a case analysis of overcoming immunotherapy resistance and literature review

  • by Yefei Ruan, Lin Qiu

  • May 12, 2026

Related Content

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report